PAH rs121908294: Understanding the p.Arg408Trp Variant
The rs121908294 variant, also known as p.Arg408Trp, is a well-documented missense mutation in the PAH gene. It is strongly associated with classic phenylketonuria (PKU), an autosomal recessive metabolic disorder.
What each genotype means
Typical enzyme activity
You carry two non-variant copies of the PAH gene at this location, corresponding to normal phenylalanine hydroxylase activity. You are not a carrier of the classic p.Arg408Trp variant associated with phenylketonuria (PKU). This genotype does not increase the likelihood of passing this specific severe PKU variant to offspring.
Carried by more than 99% of people across most global populations.
Phenylketonuria carrier
You carry one copy of the pathogenic p.Arg408Trp (c.1222C>T) variant alongside one normal copy, making you an unaffected carrier for autosomal recessive phenylketonuria. Heterozygous carriers maintain sufficient functional enzyme levels and do not develop clinical PKU symptoms. There is a 50% probability of passing this variant to future children, which is clinically relevant if reproductive partners are also carriers.
Carried by roughly 1 in 100 to 1 in 150 individuals in Central and Eastern Europe, but occurs in under 1 in 1,000 individuals in most non-European ancestries.
Severe enzyme deficiency
You carry two copies of the pathogenic p.Arg408Trp variant, which severely disrupts the phenylalanine hydroxylase enzyme complex and results in near-total loss of metabolic activity. In population and clinical genetics, this homozygous genotype is classically associated with severe, classic phenylketonuria requiring strict dietary phenylalanine management from infancy. Individuals identified with this genotype should review their metabolic care history and lab results with a biochemical geneticist or metabolic physician.
Extremely rare in the general population, typically occurring in fewer than 1 in 50,000 to 1 in 100,000 individuals globally.
What is the rs121908294 Variant?
The variant rs121908294, commonly referred to as p.Arg408Trp or R408W, is a single nucleotide change in the PAH gene. Specifically, it involves a substitution of the nucleotide cytosine (C) with thymine (T) at position 1222 of the coding sequence. This genetic alteration results in a missense mutation where the amino acid arginine is replaced by tryptophan at position 408 of the resulting protein. This variant is located in exon 12 of the PAH gene, which is situated on chromosome 12. Because it alters the primary structure of the protein, it is classified as a pathogenic variant in the context of phenylalanine hydroxylase deficiency. It is one of the most frequently studied variants in the PAH gene, serving as a benchmark for understanding the genetic architecture of metabolic conditions.
The Role of the PAH Gene
The PAH gene provides instructions for creating an enzyme called phenylalanine hydroxylase. This enzyme is primarily active in the liver and is responsible for the essential task of converting the amino acid phenylalanine into another amino acid called tyrosine. Tyrosine is a building block for several important neurotransmitters and hormones. When the PAH gene contains pathogenic variants, the resulting enzyme may be unstable, inactive, or produced in insufficient quantities. This leads to an accumulation of phenylalanine in the blood and brain, which can be toxic if left unmanaged. Because the condition is inherited in an autosomal recessive pattern, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to experience the clinical symptoms associated with classic phenylketonuria.
Research and Clinical Associations
Scientific literature consistently identifies rs121908294 as a primary cause of classic phenylketonuria (PKU). Research indicates that this variant is responsible for a significant percentage of PKU cases, particularly in European populations. Because it is a severe mutation, it is often linked to the classic form of the disorder, which requires strict dietary management to prevent the accumulation of phenylalanine to neurotoxic levels. While the evidence linking this specific variant to PKU is strong, the clinical presentation can vary based on the second variant present on the other chromosome in compound heterozygous individuals. Current research is even exploring advanced therapeutic strategies, such as base editing, to potentially correct this specific mutation at the genetic level. As with all genetic findings, this information is for educational purposes and should be discussed with a medical geneticist or clinician for personalized health context.
Population Frequency
The frequency of the rs121908294 variant varies significantly across different global populations. It is notably more common in European populations, particularly in Eastern Europe, where it has been identified as a major contributor to the local prevalence of PKU. In general population databases like gnomAD, the variant is found at a low frequency, which is consistent with its status as a pathogenic variant for a recessive condition. Because it is a rare, disease-causing variant, it is not typically found at high levels in the general, healthy population. Researchers use these frequency data to help distinguish between common benign variations and rare pathogenic mutations that require clinical attention. Understanding these patterns helps public health officials and clinicians better anticipate the needs of specific communities regarding newborn screening and genetic counseling.
Managing Genetic Information
Learning that you or a family member carries the rs121908294 variant does not constitute a medical diagnosis. Because PKU is an autosomal recessive condition, being a carrier (having only one copy of the variant) generally does not result in the clinical symptoms of the disease. However, if you are concerned about your carrier status or family history, the most appropriate step is to consult with a certified genetic counselor or a medical professional. They can provide context based on your specific family history and explain the implications of genetic testing. You cannot use this information to self-diagnose or alter any medical treatments. Always rely on professional clinical guidance for interpreting genetic reports and making decisions regarding reproductive health or long-term medical management.
How common is this variant?
The rs121908294 variant is most common in European populations, particularly in Eastern Europe, where it is a frequent cause of phenylketonuria.
Frequently asked questions
What is the rs121908294 variant?
The rs121908294 variant is a specific genetic change in the PAH gene, also known as p.Arg408Trp. It is a well-studied mutation associated with phenylketonuria (PKU).
Does having this variant mean I have PKU?
Not necessarily. PKU is an autosomal recessive condition, meaning it usually requires two copies of a pathogenic variant to manifest. If you have only one copy, you are a carrier and typically do not have the disease.
How is this variant inherited?
This variant is inherited in an autosomal recessive pattern. This means a child must inherit one copy of the variant from each parent to be at risk for developing classic PKU.
Should I be tested for this variant?
Genetic testing is a personal decision often guided by family history or reproductive planning. You should discuss the necessity and implications of such testing with a healthcare provider or a genetic counselor.
Is there a cure for the p.Arg408Trp mutation?
Currently, there is no genetic cure for this mutation. Management of PKU primarily involves strict dietary control of phenylalanine intake, though research into gene editing therapies is ongoing.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908294?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PAH
Pathogenic missense variant (p.Arg408Trp) associated with phenylketonuria (PKU).
Pathogenic phenylalanine hydroxylase variant conferring risk of phenylketonuria.
Missense variant (c.1222C>T, p.Arg408Trp) that disrupts phenylalanine hydroxylase activity, associated with phenylketonuria.
Splice-site variant (c.1066-11G>A) causing phenylalanine hydroxylase deficiency.
Missense variant (p.Arg408Trp) causing severe classic phenylketonuria (PKU) when inherited bi-allelically due to profound loss of phenylalanine hydroxylase activity.
Splice donor variant (c.1066-11G>A) associated with severe phenylalanine hydroxylase deficiency and phenylketonuria.